APA (7th ed.) Citation

LJ, Z., EJ, L., S, T., JM, v. B. H., RJ, S., LR, H., . . . EE, V. (2023). Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials. International journal of cancer, 153(7), 1413. https://doi.org/10.1002/ijc.34649

Chicago Style (17th ed.) Citation

LJ, Zeverijn, et al. "Limited Clinical Activity of Palbociclib and Ribociclib Monotherapy in Advanced Cancers with Cyclin D-CDK4/6 Pathway Alterations in the Dutch DRUP and Australian MoST Trials." International Journal of Cancer 153, no. 7 (2023): 1413. https://doi.org/10.1002/ijc.34649.

MLA (9th ed.) Citation

LJ, Zeverijn, et al. "Limited Clinical Activity of Palbociclib and Ribociclib Monotherapy in Advanced Cancers with Cyclin D-CDK4/6 Pathway Alterations in the Dutch DRUP and Australian MoST Trials." International Journal of Cancer, vol. 153, no. 7, 2023, p. 1413, https://doi.org/10.1002/ijc.34649.